IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $482,048,000 | +119218.8% | 24,784 | +2.1% | 0.01% | +40.0% |
Q4 2017 | $404,000 | -61.7% | 24,272 | -53.3% | 0.01% | -28.6% |
Q3 2017 | $1,054,000 | +26.1% | 51,945 | 0.0% | 0.01% | +16.7% |
Q2 2017 | $836,000 | +27.2% | 51,945 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $657,000 | -6.7% | 51,945 | -2.2% | 0.01% | 0.0% |
Q4 2016 | $704,000 | -44.1% | 53,112 | 0.0% | 0.01% | -44.4% |
Q3 2016 | $1,259,000 | -17.8% | 53,112 | 0.0% | 0.01% | -18.2% |
Q2 2016 | $1,531,000 | -5.6% | 53,112 | +4.9% | 0.01% | -8.3% |
Q1 2016 | $1,621,000 | -25.1% | 50,628 | 0.0% | 0.01% | -29.4% |
Q4 2015 | $2,165,000 | +21.4% | 50,628 | 0.0% | 0.02% | +30.8% |
Q3 2015 | $1,783,000 | -24.1% | 50,628 | -1.0% | 0.01% | -23.5% |
Q2 2015 | $2,349,000 | -7.2% | 51,157 | -5.3% | 0.02% | -10.5% |
Q1 2015 | $2,532,000 | +47.3% | 54,012 | -0.4% | 0.02% | +58.3% |
Q4 2014 | $1,719,000 | +33.7% | 54,256 | 0.0% | 0.01% | +33.3% |
Q3 2014 | $1,286,000 | -21.0% | 54,256 | 0.0% | 0.01% | -18.2% |
Q2 2014 | $1,627,000 | +14.2% | 54,256 | +0.6% | 0.01% | +10.0% |
Q1 2014 | $1,425,000 | +5.1% | 53,949 | 0.0% | 0.01% | 0.0% |
Q4 2013 | $1,356,000 | +22.6% | 53,949 | +0.1% | 0.01% | +25.0% |
Q3 2013 | $1,106,000 | +2.9% | 53,905 | 0.0% | 0.01% | -11.1% |
Q2 2013 | $1,075,000 | – | 53,905 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |